Growth Metrics

Integra Lifesciences Holdings (IART) Non-Current Assets (2016 - 2026)

Integra Lifesciences Holdings' Non-Current Assets history spans 17 years, with the latest figure at $2.4 billion for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 17.37% to $2.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $10.4 billion, a 9.79% decrease, with the full-year FY2025 number at $2.4 billion, down 17.37% from a year prior.
  • Non-Current Assets hit $2.4 billion in Q4 2025 for Integra Lifesciences Holdings, down from $2.5 billion in the prior quarter.
  • Over the last five years, Non-Current Assets for IART hit a ceiling of $3.0 billion in Q3 2024 and a floor of $2.4 billion in Q4 2025.
  • Historically, Non-Current Assets has averaged $2.7 billion across 5 years, with a median of $2.7 billion in 2021.
  • Biggest five-year swings in Non-Current Assets: increased 16.04% in 2021 and later decreased 17.37% in 2025.
  • Tracing IART's Non-Current Assets over 5 years: stood at $2.6 billion in 2021, then increased by 3.79% to $2.7 billion in 2022, then dropped by 0.16% to $2.7 billion in 2023, then rose by 8.51% to $3.0 billion in 2024, then decreased by 17.37% to $2.4 billion in 2025.
  • Business Quant data shows Non-Current Assets for IART at $2.4 billion in Q4 2025, $2.5 billion in Q3 2025, and $2.5 billion in Q2 2025.